Skip to main content
Acne Scar & Skin Quality

Rejuran

2% PN backed by a longer published evidence history

Rejuran Healer contains sodium polynucleotide 20 mg/mL (2% PN). Its differentiator on this page is not a higher concentration than Vitaran, but a longer history of direct clinical publications. A physician still confirms the exact product, area and realistic outcome before treatment.

Rejuran polynucleotide skin healing — Hori Clinic Bangkok

Quick answer

Rejuran: what to know first

Rejuran Healer and the comparable Vitaran I/II formulations both contain 20 mg/mL (2% PN). Rejuran is positioned here for people who value its longer publication history and direct Rejuran studies. The evidence is useful but not uniform in quality, so it supports informed discussion rather than a guaranteed individual result.

Best fit
People who want a longer direct research history for facial fine lines and skin quality
Discuss first
Pregnancy or breastfeeding, infection, medicines, allergies and relevant medical history
Downtime
Small bumps, redness, swelling or bruising can last from hours to a few days
See discomfort, timing, evidence and alternatives
Concentration
Rejuran Healer: sodium PN 20 mg/mL (2%)
Discomfort
Brief stinging or pressure at injection points; topical anaesthetic may be used
Assessment timing
Change is gradual and should be reviewed after the planned course
Compare
Vitaran 2% PN when comfort and a dewy-skin goal are higher priorities
Page summary — choose a section

Jump to the answer you need. The complete medical details and evidence remain below.

Skin Booster

What is Rejuran?

Rejuran is a product family. The formula discussed here is Rejuran Healer, documented as sodium polynucleotide 20 mg/mL (2% PN) for facial skin-quality and fine-line assessment. Other Rejuran variants can differ, so the box, formulation and treatment area must be confirmed before injection.

Rejuran has direct clinical publications going back at least to a 2014 phase III split-face trial, plus later randomized comparisons. A 2024 systematic review still judged the wider injectable-PN evidence as low to moderate quality and heterogeneous. This is a stronger publication history, not a promise that Rejuran will outperform another 2% PN product for every person.

How it works

01

Confirm the named formulation, treatment area and whether a PN injection matches the main concern.

02

Plan injection depth, spacing and aftercare from the area and medical history.

03

Review gradual skin-quality change and adverse effects before deciding on another session.

Why it may help

Why Rejuran

  • Rejuran Healer is documented at 20 mg/mL (2% PN)
  • Direct randomized Rejuran studies have been published since at least 2014
  • Focuses on facial fine lines and skin quality rather than structural volume
  • Evidence is presented with study size and limitations, not as a guaranteed result
Published evidence

Why Rejuran is the evidence-led option

2014 · Direct phase III trial

A randomized, double-blind matched-pair trial studied Rejuran against a hyaluronic-acid comparator for crow's feet in 72 participants.

2024 · Large randomized comparison

A randomized evaluator-blinded split-face study used Rejuran as the PN comparator in 218 Asian participants with crow's feet.

2024 · Systematic review

Nine injectable-PN studies involving 219 patients showed promising outcomes, but the review rated the evidence low to moderate quality with varied protocols.

Evidence level: strong for the existence of randomized comparisons, moderate for predicting an individual skin-quality result. Study formulation, area and technique may not match every clinic protocol.

A doctor may consider it for

  • Facial fine lines or early textural change
  • A skin-quality goal rather than structural reshaping
  • Able to accept temporary injection bumps, redness or bruising
  • Understands that published PN evidence does not guarantee an individual result

On the day and afterwards

After confirming the named formulation and treatment area, the physician plans the injection depth and pattern. Topical anaesthetic may be used. Session time and the number of visits depend on the area, technique, response and treatment goal rather than a fixed package.

Small bumps, redness, swelling, tenderness or bruising may last from hours to a few days. Follow the clinic’s guidance on cleansing, skincare, make-up, exercise and when to seek medical review.

When changes may appear

Any skin-quality change should be assessed gradually with comparable photographs and follow-up rather than judged from temporary post-injection swelling. The need for another session depends on response, side effects and the original goal.

Everyone responds differently. Before treatment, your doctor will examine the area and talk through a plan that makes sense for you.

Rejuran, answered.

How much PN is in Rejuran Healer?+

Its product documentation lists sodium polynucleotide 20 mg/mL, equivalent to 2% PN. Other Rejuran variants can differ, so confirm the named formulation.

How is it different from Vitaran?+

Rejuran Healer and comparable Vitaran I/II formulations are both 20 mg/mL (2% PN). Rejuran's page emphasizes its longer direct publication history; Vitaran's page emphasizes comfort evidence and a dewy-skin goal. This positioning does not prove one is universally better.

Does Rejuran have clinical research?+

Yes. Direct randomized Rejuran comparisons have been published since at least 2014. The wider PN literature remains heterogeneous, so research supports discussion but cannot predict an individual result.

Is there downtime?+

Small bumps, redness, swelling, tenderness or bruising may last from hours to a few days. Recovery varies by area, technique and individual response.

Medical decision support

Suitability, precautions and realistic expectations

May be suitable for

  • Facial fine lines or early textural change when skin quality is the main goal
  • People who want a PN option rather than filler-like volume
  • Cases in which the selected Rejuran formulation and injection area are appropriate

Tell the doctor before treatment

  • Pregnancy or breastfeeding, active infection, inflammation or open wounds
  • Medicines that affect bleeding, previous injection reactions and relevant allergies
  • The exact Rejuran formulation, treatment area, technique and follow-up plan

Possible effects and limits

  • Small bumps, redness, swelling, tenderness or bruising can occur after injection
  • Infection, allergic reaction, nodules or vascular complications are uncommon but require prompt assessment
  • Published PN studies are small and heterogeneous, so they do not guarantee a result for every Rejuran formulation

Evidence and product information

  1. Rejuran Thailand: product brochure and 2% PN composition
  2. PubMed: 2014 phase III matched-pair Rejuran trial
  3. PubMed: systematic review of injectable polynucleotides
  4. PubMed: randomized PN versus hyaluronic-acid study

Rejuran has a longer direct publication history, but the wider PN evidence remains low to moderate quality and heterogeneous. Study results cannot guarantee the same outcome for every formulation, area, technique or person.

This page provides general information and is not a diagnosis. A physician must review your medical history, skin or tissue condition, previous procedures and goals before recommending treatment.

Rejuran Bangkok at Hori Clinic Bangkok

Your treatment is performed by a doctor

Dr. Peerapol Riawraengsattha (Dr. Lhong)

Anesthesiology · Aesthetic Medicine · Thai medical licence 58253

Meet the doctors →

Not sure where to start? Talk to us on LINE.

Tell us what you are concerned about. Our team can help you prepare for a conversation with the doctor.

Chat with @horiclinic

Before you decide

A few things to know about Polynucleotide injections

We last reviewed these sources on 23 July 2026. They can help you prepare for a consultation, but they cannot replace an examination or a consent discussion with your doctor.

What the evidence says

A systematic review found promising results for polynucleotide injections, but included only nine low- or moderate-quality studies with varied techniques and treatment areas.

Risks worth discussing

Temporary injection reactions can occur and product composition differs. Suitability and expected benefit should be discussed without assuming that one brand or protocol represents the whole evidence base.

Tell us before you book

  • Ask which exact product or device will be used and where.
  • Tell us about medicines, allergies, pregnancy, medical conditions and recent procedures.
  • Ask about alternatives, recovery and warning signs.
Sources we reviewed
  1. PharmaResearch: REJURAN product information
  2. Systematic review: polynucleotides in aesthetic medicine

Regulatory references describe their own jurisdictions and are used for safety context; they do not by themselves establish Thai registration or an indication for a specific product.

The final choice depends on an examination by a licensed doctor. Meet the doctors